Literature DB >> 4790601

U-42, 126, a new antimetabolite antibiotic: production, biological activity, and taxonomy of the producing microorganism.

L J Hanka, A Dietz.   

Abstract

A new antimetabolite antibiotic, U-42,126, was discovered by use of a specific in vitro screen. U-42,126 was produced by the fermentation of Streptomyces sviceus. Its antimicrobial activity in vitro was limited to fungi. Certain bacteria were inhibited only when cultivated in completely synthetic media. U-42,126 was active in vivo against L1210 leukemia in mice.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4790601      PMCID: PMC444426          DOI: 10.1128/AAC.3.3.425

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  System of color wheels for streptomycete taxonomy.

Authors:  H D TRESNER; E J BACKUS
Journal:  Appl Microbiol       Date:  1963-07

2.  A guide for the classification of streptomycetes according to selected groups; placement of strains in morphological sections.

Authors:  T G PRIDHAM; C W HESSELTINE; R G BENEDICT
Journal:  Appl Microbiol       Date:  1958-01

3.  Ektachrome transparencies as aids in actinomycete classification.

Authors:  A DIETZ
Journal:  Ann N Y Acad Sci       Date:  1954-10-29       Impact factor: 5.691

4.  The Utilization of Carbon Compounds by Some Actinomycetales as an Aid for Species Determination.

Authors:  T G Pridham; D Gottlieb
Journal:  J Bacteriol       Date:  1948-07       Impact factor: 3.490

5.  Classification of Streptomyces spore surfaces into five groups.

Authors:  A Dietz; J Mathews
Journal:  Appl Microbiol       Date:  1971-03

6.  [Formation of antibiotics antimetabolites of amino acids and vitamins by Actinomyces].

Authors:  T P Korobkova; T S Maximova; I N Kovsharova; L P Terekhova
Journal:  Antibiotiki       Date:  1971-01

7.  Microbiological production of 5-azacytidine. I. Production and biological activity.

Authors:  L J Hanka; J S Evans; D J Mason; A Dietz
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

8.  Naturally occurring antimetabolite antibiotic related to biotin.

Authors:  L J Hanka; M E Bergy; R B Kelly
Journal:  Science       Date:  1966-12-30       Impact factor: 47.728

9.  Streptomyces steffisburgensis sp.n.

Authors:  A Dietz
Journal:  J Bacteriol       Date:  1967-12       Impact factor: 3.490

10.  Two new antimetabolites of biotin: alpha-methyldethiobiotin and alpha-methylbiotin.

Authors:  L J Hanka; D G Martin; L M Reineke
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

  10 in total
  5 in total

1.  Improved methods for production, isolation, and assay of two new chlorisoxazoline amino acid antitumor antimetabolites: U-42, 126 and U43, 795.

Authors:  L J Hanka; S A Gerpheid; P R Spieles; D G Martin; P A Belter; T A Coleman; H F Meyer
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

2.  New natural products of interest under development at the National Cancer Institute.

Authors:  J Douros; M Suffness
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

3.  Targeted Rediscovery and Biosynthesis of the Farnesyl-Transferase Inhibitor Pepticinnamin E.

Authors:  Kevin C Santa Maria; Andrew N Chan; Erinn M O'Neill; Bo Li
Journal:  Chembiochem       Date:  2019-05-02       Impact factor: 3.164

4.  Target discovery of acivicin in cancer cells elucidates its mechanism of growth inhibition†Electronic supplementary information (ESI) available: Synthesis, cloning, protein expression, purification and biochemical assays. See DOI: 10.1039/c4sc02339k.

Authors:  Johannes Kreuzer; Nina C Bach; Daniel Forler; Stephan A Sieber
Journal:  Chem Sci       Date:  2014-09-26       Impact factor: 9.825

5.  Characterization of the alkaline laccase Ssl1 from Streptomyces sviceus with unusual properties discovered by genome mining.

Authors:  Matthias Gunne; Vlada B Urlacher
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.